Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 519 (3) , 533-539
Abstract
No abstract availableKeywords
Funding Information
- Yunnan Provincial Department of Education
- National Natural Science Foundation of China
This publication has 32 references indexed in Scilit:
- Population‐based prognostic factors for survival in patients with Burkitt lymphoma: An analysis from the Surveillance, Epidemiology, and End Results databaseCancer, 2013
- Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 casesBlood, 2013
- Mammalian proapoptotic factor ChaC1 and its homologues function as γ‐glutamyl cyclotransferases acting specifically on glutathioneEMBO Reports, 2012
- Qinghaosu (artemisinin): Chemistry and pharmacologyActa Pharmacologica Sinica, 2012
- Ironing Out Cell Death MechanismsCell, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicineNature Medicine, 2011
- Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene ExpressionJournal of Biological Chemistry, 2009
- Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin CompoundsJournal of Biological Chemistry, 2007
- Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrinCancer Letters, 1995